Adverse events (not reported) · asymptomatic carotid stenosis
Antiplatelet agent showed no clear difference in adverse events (not reported) compared with placebo (low certainty).
1 finding from 1 review
Quality of life · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Outcomes (measurement/time point) · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peak IL‐6 (between the end of surgery and 24 hours post‐surgery)
1 finding from 1 review
Intervention not reported
Peak IL‐8 (between the end of surgery and 6 hours post‐surgery)
1 finding from 1 review
Intervention not reported
Hospital or 30‐day mortality
It is very uncertain whether the intervention changes hospital or 30‐day mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Myocardial injury (hospital stay)
It is very uncertain whether the intervention changes myocardial injury (hospital stay) (very low certainty).
1 finding from 1 review
Intervention not reported
Kidney injury (safety outcome) (hospital stay)
The intervention showed no clear difference in kidney injury (safety outcome) (hospital stay) (low certainty).
1 finding from 1 review
Intervention not reported
Surgical Site Infection (hospital stay)
The intervention showed no clear difference in surgical Site Infection (hospital stay) (low certainty).
1 finding from 1 review
Intervention not reported
Duration of hospital length of stay
1 finding from 1 review
Intervention not reported
Adherence to treatment (number of participants undertaking physical activity) · people with CF
It is very uncertain whether the intervention changes adherence to treatment (number of participants undertaking physical… (very low certainty).
1 finding from 1 review
Intervention not reported
Frequency of hospitalisation for respiratory infection · people with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Frequency of non‐hospitalised respiratory infection · people with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
FEV1 % predicted (change from baseline) · people with CF
It is very uncertain whether the intervention changes FEV1 % predicted (change from baseline) (very low certainty).
1 finding from 1 review
Intervention not reported
FVC % predicted (change from baseline) · people with CF
It is very uncertain whether the intervention changes FVC % predicted (change from baseline) (very low certainty).
1 finding from 1 review
Intervention not reported
QoL (change from baseline) · people with CF
1 finding from 1 review
Intervention not reported
Exercise capacity (change from baseline) VO2 peak · people with CF
It is very uncertain whether the intervention changes exercise capacity (change from baseline) VO2 peak (very low certainty).
1 finding from 1 review
Prosthesis use · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
no estimate extracted
1 study · 8 participants
GRADE not reported
Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review